1. Home
  2. Companies
  3. PTX
  4. Announcements

Prescient Therapeutics (ASX:PTX)

ASX announcement history & article coverage

28
Total announcements
(in last 3 months)
8
With article
20
No article
Article coverage
29%
Transparent by design. Announcments by Prescient Therapeutics (ASX:PTX) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.

23 Oct 2026 · 09:45 am AEST ASX Filing
Change of Company Secretary
Company Secretary Appointment/Resignation
14 Oct 2026 · 04:05 pm AEST ASX Filing
Results of Annual General Meeting
Results of Meeting
14 Oct 2026 · 10:47 am AEST ASX Filing
Chair Address and CEO AGM Presentation
Company PresentationChair's Address to Shareholders
13 Oct 2026 · 09:39 am AEST ⚡ Price SensitiveMaterial ASX Filing
September 2026 Quarterly Update and Appendix 4C
Prescient reaches PTX-100 trial milestone and secures $6.0 million capital raise
Commitments Test Entity - First Quarter Activity ReportWeb Cast
78
Prescient reaches PTX-100 review threshold as cash rises to A$11.8 million Healthcare Wrap - Week 42 (12 Oct -> 16 Oct) 2026 Wrap
6 Oct 2026 · 11:05 am AEST ASX Filing
Change of Director's Interest Notice
Change of Director's Interest Notice
6 Oct 2026 · 11:04 am AEST ASX Filing
Change of Director's Interest Notice
Change of Director's Interest Notice
6 Oct 2026 · 11:03 am AEST ASX Filing
Change of Director's Interest Notice
Change of Director's Interest Notice

30 Sept 2026 · 11:07 am AEST ASX Filing
Notification regarding unquoted securities - PTX
Appendix 3G
30 Sept 2026 · 09:49 am AEST ASX Filing
Section 708A Cleansing Notice
Cleansing Notice
30 Sept 2026 · 09:45 am AEST ASX Filing
Application for quotation of securities - PTX
Appendix 2A
30 Sept 2026 · 09:44 am AEST ASX Filing
Application for quotation of securities - PTX
Appendix 2A
23 Sept 2026 · 10:04 am AEST ASX Filing
Proposed issue of securities - PTX
Appendix 3B (Proposed issue of securities)
23 Sept 2026 · 10:03 am AEST ⚡ Price SensitiveMaterial ASX Filing
PTX Successfully Completes $6m Raise Via SPP and Placement
Prescient Therapeutics completes circa $6 million raise to fund PTX-100 development
PlacementTrading Halt Lifted
78
Prescient secures $6 million to carry PTX-100 beyond December review Healthcare Wrap - Week 39 (21 Sept -> 25 Sept) 2026 Wrap
21 Sept 2026 · 09:33 am AEST ⚡ Price Sensitive ASX Filing
Trading Halt
Trading Halt
15 Sept 2026 · 11:54 am AEST ASX Filing
Update - Proposed issue of securities - PTX
Appendix 3B (Proposed issue of securities)
15 Sept 2026 · 09:00 am AEST ⚡ Price SensitiveMaterial ASX Filing
Prescient Therapeutics - Extension of Share Purchase Plan
Prescient Therapeutics extends $30,000 Share Purchase Plan to 18 September
Web CastSecurity Purchase Plan
58
Prescient Extends Share Plan as PTX-100 Milestone Nears Healthcare Wrap - Week 38 (14 Sept -> 18 Sept) 2026 Wrap
14 Sept 2026 · 09:10 am AEST ASX Filing
Notice of Annual General Meeting/Proxy Form
Web CastNotice of Annual General Meeting
8 Sept 2026 · 09:18 am AEST ASX Filing
Update - Proposed issue of securities - PTX
Appendix 3B (Proposed issue of securities)
8 Sept 2026 · 09:03 am AEST ⚡ Price SensitiveMaterialUnexpected ASX Filing
Prescient Therapeutics - Extension of Share Purchase Plan
Prescient Therapeutics extends A$7 million share purchase plan to 15 September
Web CastSecurity Purchase Plan
68
Prescient Extends A$7 Million SPP as PTX-100 Funding Deadline Moves Healthcare Wrap - Week 37 (7 Sept -> 11 Sept) 2026 Wrap
2 Sept 2026 · 02:10 pm AEST ⚡ Price SensitiveMaterial ASX Filing
PTX-100 CTCL Phase 2a study reaches review milestone
Prescient Therapeutics hits Phase 2a enrolment milestone for PTX-100 CTCL study, DOC review set for December 2026
Web CastProgress Report
70

26 Aug 2026 · 09:53 am AEST ASX Filing
Prescient Share Purchase Plan Investor Presentation
Company PresentationSecurity Purchase Plan
26 Aug 2026 · 08:57 am AEST ⚡ Price SensitiveMaterial ASX Filing
Prescient Therapeutics Opens SPP to Raise $7m Today
Prescient Therapeutics launches $7 million Share Purchase Plan to advance PTX-100 clinical development
Web CastLetter to Shareholders
75
Prescient Therapeutics Launches $7 Million SPP to Propel PTX-100 Development Healthcare Wrap - Week 35 (24 Aug -> 28 Aug) 2026 Wrap
26 Aug 2026 · 08:45 am AEST ASX Filing
Share Purchase Plan Cleansing Notice
Cleansing Notice
25 Aug 2026 · 02:47 pm AEST ASX Filing
Proposed issue of securities - PTX
Appendix 3B (Proposed issue of securities)
25 Aug 2026 · 09:06 am AEST ⚡ Price SensitiveMaterial ASX Filing
Prescient Therapeutics Launches Share Purchase Plan for $7m
Prescient Therapeutics launches $7 million Share Purchase Plan to advance PTX-100 cancer therapy
Web CastSecurity Purchase Plan
75
Prescient Therapeutics Targets $7 Million SPP to Propel PTX-100 Development Healthcare Wrap - Week 35 (24 Aug -> 28 Aug) 2026 Wrap
21 Aug 2026 · 09:34 am AEST ASX Filing
Appendix 4G and Corporate Governance Statement
Corporate GovernanceAppendix 4G
21 Aug 2026 · 09:32 am AEST ⚡ Price SensitiveMaterial ASX Filing
Appendix 4E and 2026 Annual Report
Prescient Therapeutics advances PTX-100 Phase 2a trial, reduces loss by 4.4%, raises $9.8M
Annual ReportTop 20 shareholders
85
Prescient Therapeutics Advances PTX-100 Phase 2a Trial, Reduces Loss by 4.4%, Raises $9.8M Healthcare Wrap - Week 34 (17 Aug -> 21 Aug) 2026 Wrap

27 July 2026 · 12:36 pm AEST ⚡ Price SensitiveMaterial ASX Filing
June 2026 Quarterly Update and Appendix 4C
Prescient Therapeutics advances PTX-100 Phase 2a trial with increased enrolment and new CMO appointment
Commitments Test Entity - Fourth Quarter Activity ReportWeb Cast
75
Prescient Therapeutics Accelerates PTX-100 Trial Enrolment and Appoints New Chief Medical Officer Healthcare Wrap - Week 31 (27 July -> 31 July) 2026 Wrap